João RibasBest of 2023: books, podcasts, and moreAs we close the chapter on 2023, it’s time to reflect on a year that buzzed with the energy of reconnection and groundbreaking…Jan 191Jan 191
João Ribasinde novoNeuromuscular disease treatments moving in the right directionSkeletal muscles are essential for human movement and account for about 40% of the body mass. They enable various behaviors such as…Nov 15, 2023Nov 15, 2023
João Ribasinde novoAtrial Fibrillation on the Rise: Challenges and Opportunities for Safer Treatment OptionsAtrial Fibrillation (AF) is the most common type of cardiac arrhythmia, affecting an estimated 4.5 million people in Europe alone.Sep 28, 2023Sep 28, 2023
João Ribasinde novoHemab’s Blood Clotting Therapies at the heart of human resilienceWhile patients with common bleeding and thrombotic disorders have had access to preventative treatments for more than a half-century, no…May 23, 2023May 23, 2023
João Ribasinde novoInternational Day of Women and Girls in Science — interview with Asgard Therapeutics’ CEO and…Celebrating the International Day of Women and Girls in Science with an interview with Cristiana Pires, co-founder and CEO of Asgard…Feb 11, 2023Feb 11, 2023
João RibasBest of 2022: books, podcasts, and moreRead my reflection of 2022 with a collection of my thoughts, learnings and content recommendations.Jan 19, 2023Jan 19, 2023
João Ribasinde novoEntrepreneurs in and out of residence — a dual perspective on the role of EiRs in venture creationby Joao Ribas and Martin BondeMar 31, 2022Mar 31, 2022
João RibasBest of 2020: books, podcasts, and more2020 started like any other year, but quickly morphed into something new and unexpected… here are my learnings and recommendations.Jan 5, 2021Jan 5, 2021
João RibasHow many stroopwafels does it take to hack a medical problem?This past 17 and 18th of February I was in Utrecht to help organize the Avicenna Healthcare Hackathon, fueled by stroopwafels, Chocomel…Mar 24, 2018Mar 24, 2018
